-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharmaceuticals Reports Positive Safety and Efficacy Results for PH-762 in Phase 1b Skin Cancer Trial

Reuters·02/10/2026 12:03:39

Please log in to view news